is mounjaro for prediabetes

Mounjaro (tirzepatide) is primarily approved for the treatment of type 2 diabetes, not prediabetes. However, some healthcare providers may consider off-label use for prediabetes in certain cases, especially for individuals at high risk of progressing to type 2 diabetes.

• How it works: Mounjaro is a dual GIP and GLP-1 receptor agonist that helps regulate blood sugar levels and may aid in weight loss.
• For prediabetes: While not officially approved for prediabetes, its ability to improve insulin sensitivity and reduce blood sugar levels could be beneficial.

Always consult your healthcare provider to determine if Mounjaro is appropriate for your condition.